“They Call Us Cheaters”: Exploring Stigma Management Communication Strategies During GLP-1 Medication Use

As GLP-1 receptor agonist medications become more popular, conversations surrounding the medication’s use are becoming increasingly more complicated. Emerging research suggests that individuals taking these medications often feel stigmatized. However, understanding how individuals manage stigma through communication is less explored. Using stigma management communication theory, the current study seeks to better understand how individuals communicatively manage stigma surrounding GLP-1 medication use. A reflexive thematic analysis of interviews with GLP-1 users (n = 34) suggests that individuals evaluate their interpretations of both their own self-stigma and the public’s understanding of GLP-1 and engage in various different stigma management communication strategies in response. These strategies, while effective for stigma management, may inadvertently contribute to ongoing stigmatizing discourse surrounding GLP-1 use.

Authors

Institutions

Publication Details

Journal
Health Communication
Published
2026-09-18
DOI
https://doi.org/10.1080/10410236.2026.2734167
Primary Topic
Medication Adherence and Compliance
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

“They Call Us Cheaters”: Exploring Stigma Management Communication Strategies During GLP-1 Medication Use

Sarah F. Price, Braidyn Lazenby, Tursynay Alikhanova, Md Sazzad Mahmud Shuvo et al.
Health Communication
Medication Adherence and Compliance
article

“They Call Us Cheaters”: Exploring Stigma Management Communication Strategies During GLP-1 Medication Use

Sarah F. Price, Braidyn Lazenby, Tursynay Alikhanova, Md Sazzad Mahmud Shuvo, Ashley Marie Guidry, Chloe Morrison, Nicole Davis, Madison Lenard
article en

Abstract

As GLP-1 receptor agonist medications become more popular, conversations surrounding the medication’s use are becoming increasingly more complicated. Emerging research suggests that individuals taking these medications often feel stigmatized. However, understanding how individuals manage stigma through communication is less explored. Using stigma management communication theory, the current study seeks to better understand how individuals communicatively manage stigma surrounding GLP-1 medication use. A reflexive thematic analysis of interviews with GLP-1 users (n = 34) suggests that individuals evaluate their interpretations of both their own self-stigma and the public’s understanding of GLP-1 and engage in various different stigma management communication strategies in response. These strategies, while effective for stigma management, may inadvertently contribute to ongoing stigmatizing discourse surrounding GLP-1 use.

Health Communication
Florida State University (US), New York City College of Technology (US), The University of Texas at Austin (US)
Reduced inequalities
Openalex Percentile: Top 8%
Medication Adherence and Compliance
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

“They Call Us Cheaters”: Exploring Stigma Management Communication Strategies During GLP-1 Medication Use — Sarah F. Price, Braidyn Lazenby, et al. · Health Communication (2026) | TGRS Research Map | TGRS